ATE499106T1 - Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure - Google Patents

Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure

Info

Publication number
ATE499106T1
ATE499106T1 AT08835989T AT08835989T ATE499106T1 AT E499106 T1 ATE499106 T1 AT E499106T1 AT 08835989 T AT08835989 T AT 08835989T AT 08835989 T AT08835989 T AT 08835989T AT E499106 T1 ATE499106 T1 AT E499106T1
Authority
AT
Austria
Prior art keywords
hyaluronic acid
combination
tamarind seed
compositions based
ophthalmic compositions
Prior art date
Application number
AT08835989T
Other languages
English (en)
Inventor
Prete Antonio Del
Marco Sanso
Original Assignee
Rmfa Trading S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rmfa Trading S A filed Critical Rmfa Trading S A
Application granted granted Critical
Publication of ATE499106T1 publication Critical patent/ATE499106T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT08835989T 2007-10-02 2008-10-02 Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure ATE499106T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
PCT/IT2008/000626 WO2009044423A1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Publications (1)

Publication Number Publication Date
ATE499106T1 true ATE499106T1 (de) 2011-03-15

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08835989T ATE499106T1 (de) 2007-10-02 2008-10-02 Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure

Country Status (14)

Country Link
US (1) US8455462B2 (de)
EP (1) EP2197456B1 (de)
JP (1) JP5542674B2 (de)
KR (1) KR101570966B1 (de)
AT (1) ATE499106T1 (de)
CA (1) CA2701721C (de)
DE (1) DE602008005173D1 (de)
ES (1) ES2361529T3 (de)
IT (1) ITRM20070510A1 (de)
MX (1) MX2010003488A (de)
PL (1) PL2197456T3 (de)
PT (1) PT2197456E (de)
RU (1) RU2493855C2 (de)
WO (1) WO2009044423A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE429209T1 (de) * 2005-02-09 2009-05-15 Safilens S R L Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
IT1396607B1 (it) * 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
HUE026862T2 (en) 2010-05-24 2016-07-28 Indena Spa Combined vegetable extracts for use in the treatment of microbiological infections
SI2575973T1 (sl) * 2010-05-24 2017-10-30 Indena S.P.A. Polisaharid semen tamarinde in ekstrakt iz ferula hermonis, za uporabo pri zdravljenju vnetnih bolezni
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (de) * 2013-12-12 2015-06-17 Omya International AG Verbesserte Gelstabilität
US20170027980A1 (en) 2014-04-15 2017-02-02 Novintethical Pharma Sa Composition based on xyloglucan and proteins for the treatment of intestinal disorders
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
ES2705692T3 (es) 2015-06-11 2019-03-26 Novintethical Pharma Sa Composiciones nasales tópicas que contienen xiloglucanos para usar como descongestionantes
US10849918B2 (en) * 2015-07-13 2020-12-01 Tohoku Techno Arch Co., Ltd. Composition for optic nerve protection
AR108280A1 (es) 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
US10702578B2 (en) * 2017-08-02 2020-07-07 Shilpa Medicare Limited Ophthalmic compositions of cyclosporine
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
EA202190014A1 (ru) * 2018-07-18 2021-06-29 Атг 20 С.Р.Л. Композиция, содержащая глицирризин, и ее косметическое средство и фармацевтические применения

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
EP1021204B1 (de) * 1997-09-26 2005-12-28 Noven Pharmaceuticals, Inc. Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
TR200101790T2 (tr) * 1998-12-23 2001-10-22 Idea Ag. Yayılgan olmayan in vivo topik uygulamalar için geliştirilmiş formül
AU2004283091A1 (en) * 2003-10-03 2005-05-06 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
ATE429209T1 (de) * 2005-02-09 2009-05-15 Safilens S R L Kontaktlinse, verfahren zu ihrer herstellung und packung zur aufbewahrung und pflege einer kontaktlinse
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Also Published As

Publication number Publication date
KR20100091151A (ko) 2010-08-18
JP5542674B2 (ja) 2014-07-09
RU2010117173A (ru) 2011-11-10
RU2493855C2 (ru) 2013-09-27
JP2010540619A (ja) 2010-12-24
KR101570966B1 (ko) 2015-11-23
US20100279981A1 (en) 2010-11-04
WO2009044423A1 (en) 2009-04-09
CA2701721C (en) 2016-02-23
US8455462B2 (en) 2013-06-04
ES2361529T3 (es) 2011-06-17
DE602008005173D1 (de) 2011-04-07
ITRM20070510A1 (it) 2009-04-03
EP2197456A1 (de) 2010-06-23
EP2197456B1 (de) 2011-02-23
CA2701721A1 (en) 2009-04-09
MX2010003488A (es) 2010-08-31
PT2197456E (pt) 2011-05-18
PL2197456T3 (pl) 2012-07-31

Similar Documents

Publication Publication Date Title
ATE499106T1 (de) Ophthalmische zusammensetzungen auf basis von tamarinden-samen-polysacchariden und hyaluronsäure
JP2010540619A5 (de)
BRPI0519508A2 (pt) análogos de aminopirazina para tratamento de glaucoma e outras doenças ou condições mediadas por rho cinase
IN2012DN03632A (de)
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
MY159463A (en) Method and composition for treating ocular hypertension and glaucoma
MX2010003774A (es) Formulaciones oftalmicas acuosas.
MX2009004467A (es) Compuestos benzoilo amino heterociclilo como activadores de la glucoquinasa (glk).
MY148405A (en) Immunogenic composition
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
ATE554747T1 (de) Hochviskose makromolekulare zusammensetzungen zur behandlung von augenerkrankungen
TW200733964A (en) (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating rho kinase-mediated diseases and conditions
BR112012007114A2 (pt) métodos e composições para tratamento da fibrose ocular
MX351152B (es) Compstatina y analogos de la misma para tratar trastornos oculares.
ATE479453T1 (de) Polymermischungen von anionischen und kationischen polysacchariden und verwendung davon
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
NZ608202A (en) Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
BRPI0508177A (pt) composto, processo para a produção do composto, composição farmacêutica, uso do composto método para o tratamento de uma doença e produto de combinação
MY150250A (en) Ketorolac tromethamine compositions for treating or preventing ocular pain
BR112014027582A8 (pt) composições oftalmicas com proteção e retenção de dessecação aperfeiçoada
MX2019009711A (es) Mejoras en o con respecto a compuestos organicos.
HRP20231090T1 (hr) Pripravci i metode sinergističkog tretmana glikokaliksa
NO20075637L (no) 4-fenyl-5-okso-1,4,5,6,7,8-heksahydrokinolinderivater som medikamenter for behandling av infertilitet
SG179131A1 (en) Modified erythropoietin to which water-soluble long-chain molecule is added
BR112017014016A2 (pt) método de redução da pressão intraocular, e, composição farmacêutica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2197456

Country of ref document: EP